— Know what they know.
Not Investment Advice

NIKA OTC

Nika Pharmaceuticals Inc.
1W: +0.0% 1M: +0.0% 3M: -7.7% YTD: +7.9% 1Y: +40.6%
$0.41
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 41 · $429.9M mcap · 276M float · 0.0002% daily turnover · Short 65% of daily vol

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-04-12
Earliest Filing
2022-04-12
Latest Filing
partner: 2

Counterparties (Filed by NIKA)

2 relationships

Companies named in NIKA's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
VITAL FE Joint Stock Company — partner Signed an Exclusive Rights Agreement for the production and distribution of Thymus Nuclear Glycoprotein. 2022-04-12 View
MICAR 11 LTD. — partner Signed an Exclusive Rights Agreement for the production and distribution of two dietary supplements. 2022-04-12 View
Recent 8-K Filings (11)
Filing Date Description Type SEC
2024-10-16 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
2024-10-01 Changes in Registrant's Certifying Accountant View
2024-08-27 Completion of Acquisition or Disposition of Assets; Financial Statements and Exhibits Acquisition View
2024-05-10 Completion of Acquisition or Disposition of Assets; Other Events; Financial Statements and Exhibits Acquisition View
2024-02-16 Changes in Registrant's Certifying Accountant View
2023-09-18 Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregi Agreement Acquisition View
2022-11-15 Departure/Election of Directors; Appointment of Officers View
2022-11-01 Changes in Registrant's Certifying Accountant View
2022-08-22 Amendments to Articles of Incorporation or Bylaws View
2022-04-12 Completion of Acquisition or Disposition of Assets; Material Modification to Rights of Security Hold Acquisition View
2022-04-05 Departure/Election of Directors; Appointment of Officers View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms